1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. ENSYSCE BIOSCIENCES INC
Ensysce Biosciences Inc XNAS: ENSC
Download real time
2.24 0.04 (1.82%)
77.33% Fall from 52W High
25,443
XNAS Volume
High vol. this week

XNAS 15 Jul, 2025 11:12 AM (EDT)

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Ensysce Biosciences Inc

The latest disclosure was made by Bob G. Gower in Ensysce Biosciences Inc where a trade of 90,287 Common Stock done at an average price of $0.5 was reported to US exchanges on March 2, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Bob G. Gower Director Purchase of securities on an exchange or from another person at price $ 0.49 per share. 02 Mar 2023 90,287 1,222,682 - 0.5 44,087 Common Stock
Bob G. Gower Director Purchase of securities on an exchange or from another person at price $ 0.48 per share. 28 Feb 2023 270,000 1,132,395 - 0.5 128,979 Common Stock
Bob G. Gower Director Purchase of securities on an exchange or from another person at price $ 0.49 per share. 28 Feb 2023 109,300 862,395 - 0.5 53,371 Common Stock
Bob G. Gower Director Purchase of securities on an exchange or from another person at price $ 1.40 per share. 09 Dec 2022 357,143 753,095 - 1.4 500,000 Common Stock
Bob G. Gower Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2022 714,286 716,365 - - Warrants
Andrew Benton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2022 15,000 100,850 - - Stock Option
Lee Rauch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2022 15,000 35,000 - - Stock Option
Steven R. Martin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2022 15,000 100,850 - - Stock Option
Bob G. Gower Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2022 15,000 41,585 - - Stock Option
Adam S. Levin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2022 15,000 35,000 - - Stock Option
Curtis Rosebraugh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2022 20,000 35,000 - - Stock Option
David Humphrey Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2022 80,000 80,000 - - Stock Option
Kevin Geoffrey Birkett Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2022 50,000 50,000 - - Stock Option
Steven R. Martin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 20,000 20,000 - - Stock Option
Bob G. Gower Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 20,000 20,000 - - Stock Option
David Humphrey Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 275,000 275,000 - - Stock Option
Andrew Benton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 20,000 20,000 - - Stock Option
Adam S. Levin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 20,000 20,000 - - Stock Option
Curtis Rosebraugh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 20,000 20,000 - - Stock Option
Linda Pestano Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 200,000 200,000 - - Stock Option
A. Lorne Weil Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 1,000,000 1,000,000 - - Warrants
A. Lorne Weil Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 30 Jun 2021 250,000 137,895 - - Warrants
A. Lorne Weil Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 387,895 387,895 - - Warrants
Bob G. Gower Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 6,585 6,585 - - Stock Option
A. Lorne Weil Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 730,110 730,110 - - Warrants
Bob G. Gower Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 7,919,026 7,919,026 - - Common Stock
Kevin Geoffrey Birkett Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 19,755 19,755 - - Stock Option
Kevin Geoffrey Birkett Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 329,250 329,250 - - Stock Option
Andrew Benton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 65,850 65,850 - - Stock Option
William K. Schmidt Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 69,142 69,142 - - Stock Option
Richard Wright Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 19,755 19,755 - - Stock Option
Richard Wright Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 263,400 263,400 - - Stock Option
Richard Wright Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 65,850 65,850 - - Stock Option
Richard Wright Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 49,975 49,975 - - Stock Option
Richard Wright Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 987,750 987,750 - - Stock Option
David Humphrey Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 50,000 50,000 - 0 Common Stock
George Peng Former officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 15,000 15,000 - - Warrants
Steven R. Martin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 65,850 65,850 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters